The shieldin complex mediates 53BP1-dependent DNA repair

Area of Science:

• Molecular Biology
• DNA Repair Mechanisms
• Cancer Biology

Background:

• 53BP1 protein regulates DNA double-strand break repair by inhibiting DNA end resection.
• The mechanism by which 53BP1 and its associated proteins shield DNA ends was previously unknown.
• Two models proposed 53BP1's action: strengthening nucleosomal barriers or recruiting effector proteins.

Purpose of the Study:

• To identify the effector complex responsible for 53BP1-mediated DNA end protection.
• To elucidate the mechanism of DNA end shielding in DNA double-strand break repair.
• To investigate the role of shieldin in DNA repair pathways and its implications for cancer therapy.

Main Methods:

• Identification and characterization of the shieldin complex, including its subunits (SHLD1, SHLD2, SHLD3, REV7).
• Localization studies of shieldin at DNA break sites.
• Biochemical assays to determine SHLD2's interaction with single-stranded DNA (ssDNA) and functional analyses of shieldin in DNA repair processes.

Main Results:

• Shieldin, composed of C20orf196 (SHLD1), FAM35A (SHLD2), CTC-534A2.2 (SHLD3), and REV7, was identified as a 53BP1 effector complex.
• Shieldin localizes to DNA break sites in a 53BP1 and RIF1-dependent manner; SHLD2 binds ssDNA.
• Loss of shieldin impairs non-homologous end-joining, affects immunoglobulin class switching, causes hyper-resection, and confers resistance to PARP inhibition in BRCA1-deficient cells by restoring homologous recombination.

Conclusions:

• Shieldin directly binds to single-stranded DNA via its SHLD2 subunit, playing a critical role in protecting DNA ends.
• This mechanism is consistent with shieldin mediating 53BP1-dependent DNA repair by preventing excessive resection.
• The findings reveal shieldin as a key component of the DNA repair machinery with significant implications for understanding cancer development and therapeutic resistance.